We are monitoring the impact of COVID-19 on Asia Pacific Aptamers Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1074
Share on
Share on

Asia Pacific Aptamers Market Research Report - Segmented By Type, Application, End User, & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: August, 2019
ID: 1074
Pages: 145

Asia Pacific Aptamers Market Size & Growth (2019 – 2024):

The Size of the Asia Pacific Aptamers Market is valued at USD 33.42 million in 2019 and estimated to reach USD 92.18 million by the end of 2024, to grow at a CAGR of 22.5 % during the forecast period 2019-2024.

Aptamers are oligonucleotides that bind to a target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can be chosen from a pool of random-sequence oligonucleotides to bind a wide range of biomedically relevant proteins with specificities and affinities that are as good as antibodies. Aptamers are multipurpose and cost-effective which offer alternative solutions to the antibodies. Aptamers exhibit important advantages relative to protein therapeutics in terms of synthetic accessibility, size, and modification by medicinal chemistry.

The Major factors driving the growth of the Asia - Pacific market are an advancement in technology, Growing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy of aptamers in binding. Ethical issues for the aptamers that are obtained from animals, Stringent regulations in the use of aptamers may hinder the growth of the market.  

This research report segmented and sub-segmented the Asia Pacific Aptamers Market into the following categories:

  • By Type: Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.
  • By  Application: Therapeutics Development, Diagnostics, Research and Development
  • By End User: Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

Some of the Prominent companies dominating the Asia Pacific Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Aptamers Market By Type, From 2019-2024( USD Million )
  2. Asia-Pacific Peptide Aptamers Market By Region, From 2019-2024( USD Million )
  3. Asia-Pacific Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Million )
  4. Asia-Pacific Aptamers Market By Application, From 2019-2024( USD Million )
  5. Asia-Pacific Therapeutics Development Market By Region, From 2019-2024( USD Million )
  6. Asia-Pacific Diagnostics Market By Region, From 2019-2024( USD Million )
  7. Asia-Pacific Research and Development Market By Region, From 2019-2024( USD Million )
  8. Asia-Pacific Aptamers Market By End users, From 2019-2024( USD Million )
  9. Asia-Pacific Pharmaceutical Companies Market By Region, From 2019-2024( USD Million )
  10. Asia-Pacific Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Million )
  11. Asia-Pacific Academic and Rsearch centers Market By Region, From 2019-2024( USD Million )
  12. Japan Aptamers Market By Type, From 2019-2024( USD Million )
  13. Japan Aptamers Market By Application, From 2019-2024( USD Million )
  14. Japan Aptamers Market By End users, From 2019-2024( USD Million )
  15. China Aptamers Market By Type, From 2019-2024( USD Million )
  16. China Aptamers Market By Application, From 2019-2024( USD Million )
  17. China Aptamers Market By End users, From 2019-2024( USD Million )
  18. India Aptamers Market By Type, From 2019-2024( USD Million )
  19. India Aptamers Market By Application, From 2019-2024( USD Million )
  20. India Aptamers Market By End users, From 2019-2024( USD Million )
  21. Australia Aptamers Market By Type, From 2019-2024( USD Million )
  22. Australia Aptamers Market By Application, From 2019-2024( USD Million )
  23. Australia Aptamers Market By End users, From 2019-2024( USD Million )
  24. Asia-Pacific Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  25. Asia-Pacific DNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  26. Asia-Pacific RNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  27. Asia-Pacific XNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  28. Japan Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  29. China Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  30. India Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample